Major shareholders reduce stakes in Beijing Aosaikang Pharmaceutical

Jiangsu Suyang Investment Industrial Co., a shareholder holding over 5% of Beijing Aosaikang Pharmaceutical, announced the completion of its share reduction plan as of November 17, 2025. The company reduced its holdings by 13,914,802 shares, or 1.50% of the total share capital, through centralized bidding and block trades. Following this, Jiangsu Suyang Investment holds 110,500,560 shares, accounting for 11.91% of the company's total share capital.

Concurrently, Zhongyi Weiye Holdings Limited, another significant shareholder, reduced its stake in Beijing Aosaikang Pharmaceutical between September 9 and November 14, 2025. Zhongyi Weiye decreased its holdings by 8,812,803 shares, representing 0.95% of the total share capital, through centralized bidding and block transactions. This brought Zhongyi Weiye's total holdings down from 12.95% to 12.00%, now 111,379,230 shares.

Both share reductions were executed according to previously disclosed plans and did not result in a change of control for Beijing Aosaikang Pharmaceutical, nor are they expected to significantly impact the company's operations.